Electron Transport Chain (see tricarboxylic acid section for Complex II), Cytochrome c oxidase subunit IV
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9AGF4
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0016491 | oxidoreductase activity | 2 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 128 | 132 | PF00656 | 0.632 |
CLV_NRD_NRD_1 | 231 | 233 | PF00675 | 0.486 |
CLV_NRD_NRD_1 | 25 | 27 | PF00675 | 0.611 |
CLV_NRD_NRD_1 | 332 | 334 | PF00675 | 0.501 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.591 |
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.589 |
CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.611 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.586 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.536 |
CLV_PCSK_SKI1_1 | 233 | 237 | PF00082 | 0.494 |
CLV_PCSK_SKI1_1 | 274 | 278 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 334 | 338 | PF00082 | 0.572 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.518 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.596 |
DEG_SPOP_SBC_1 | 16 | 20 | PF00917 | 0.729 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 186 | 193 | PF00134 | 0.679 |
DOC_MAPK_DCC_7 | 68 | 76 | PF00069 | 0.551 |
DOC_MAPK_gen_1 | 232 | 238 | PF00069 | 0.492 |
DOC_MAPK_MEF2A_6 | 68 | 76 | PF00069 | 0.551 |
DOC_USP7_MATH_1 | 16 | 20 | PF00917 | 0.727 |
DOC_USP7_MATH_1 | 280 | 284 | PF00917 | 0.545 |
DOC_USP7_UBL2_3 | 334 | 338 | PF12436 | 0.477 |
DOC_USP7_UBL2_3 | 55 | 59 | PF12436 | 0.706 |
DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.574 |
LIG_14-3-3_CanoR_1 | 204 | 210 | PF00244 | 0.514 |
LIG_14-3-3_CanoR_1 | 274 | 279 | PF00244 | 0.489 |
LIG_14-3-3_CanoR_1 | 4 | 8 | PF00244 | 0.555 |
LIG_APCC_ABBA_1 | 70 | 75 | PF00400 | 0.557 |
LIG_CSL_BTD_1 | 207 | 210 | PF09270 | 0.512 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.515 |
LIG_FHA_1 | 271 | 277 | PF00498 | 0.503 |
LIG_FHA_2 | 126 | 132 | PF00498 | 0.645 |
LIG_FHA_2 | 260 | 266 | PF00498 | 0.554 |
LIG_FHA_2 | 335 | 341 | PF00498 | 0.545 |
LIG_FHA_2 | 58 | 64 | PF00498 | 0.530 |
LIG_LIR_Gen_1 | 211 | 221 | PF02991 | 0.515 |
LIG_LIR_Gen_1 | 78 | 87 | PF02991 | 0.559 |
LIG_LIR_Nem_3 | 211 | 216 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 219 | 224 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 331 | 335 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 78 | 83 | PF02991 | 0.565 |
LIG_PDZ_Class_1 | 338 | 343 | PF00595 | 0.587 |
LIG_SH2_CRK | 213 | 217 | PF00017 | 0.532 |
LIG_SH2_GRB2like | 255 | 258 | PF00017 | 0.390 |
LIG_SH2_NCK_1 | 310 | 314 | PF00017 | 0.404 |
LIG_SH2_STAP1 | 246 | 250 | PF00017 | 0.458 |
LIG_SH2_STAP1 | 255 | 259 | PF00017 | 0.426 |
LIG_SH2_STAP1 | 310 | 314 | PF00017 | 0.404 |
LIG_SH2_STAP1 | 80 | 84 | PF00017 | 0.556 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.546 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.532 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.605 |
LIG_SUMO_SIM_anti_2 | 234 | 241 | PF11976 | 0.512 |
LIG_SUMO_SIM_par_1 | 234 | 241 | PF11976 | 0.540 |
LIG_TRAF2_1 | 60 | 63 | PF00917 | 0.538 |
MOD_CK1_1 | 177 | 183 | PF00069 | 0.557 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.666 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.558 |
MOD_CK2_1 | 259 | 265 | PF00069 | 0.506 |
MOD_CK2_1 | 334 | 340 | PF00069 | 0.537 |
MOD_CK2_1 | 57 | 63 | PF00069 | 0.550 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.561 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.664 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.664 |
MOD_GSK3_1 | 270 | 277 | PF00069 | 0.425 |
MOD_GSK3_1 | 334 | 341 | PF00069 | 0.543 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.682 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.549 |
MOD_N-GLC_1 | 338 | 343 | PF02516 | 0.665 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.620 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.534 |
MOD_NEK2_1 | 66 | 71 | PF00069 | 0.516 |
MOD_NEK2_2 | 280 | 285 | PF00069 | 0.461 |
MOD_PKA_2 | 203 | 209 | PF00069 | 0.517 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.526 |
MOD_Plk_1 | 135 | 141 | PF00069 | 0.504 |
MOD_Plk_1 | 182 | 188 | PF00069 | 0.547 |
MOD_Plk_1 | 61 | 67 | PF00069 | 0.561 |
MOD_Plk_4 | 135 | 141 | PF00069 | 0.504 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.584 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.510 |
MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.568 |
MOD_SUMO_for_1 | 58 | 61 | PF00179 | 0.667 |
MOD_SUMO_rev_2 | 146 | 156 | PF00179 | 0.511 |
MOD_SUMO_rev_2 | 252 | 262 | PF00179 | 0.502 |
TRG_DiLeu_BaEn_1 | 321 | 326 | PF01217 | 0.511 |
TRG_ENDOCYTIC_2 | 213 | 216 | PF00928 | 0.531 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.552 |
TRG_ER_diArg_1 | 25 | 27 | PF00400 | 0.627 |
TRG_PTS1 | 340 | 343 | PF00515 | 0.601 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HRY9 | Leptomonas seymouri | 89% | 100% |
A0A0S4JH93 | Bodo saltans | 72% | 99% |
A0A1X0NMQ0 | Trypanosomatidae | 76% | 100% |
A0A3R7NBF6 | Trypanosoma rangeli | 78% | 100% |
A0A3S5H6L2 | Leishmania donovani | 100% | 100% |
A4H6Y0 | Leishmania braziliensis | 91% | 100% |
C9ZHY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 97% |
E9ANZ4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4QGM6 | Leishmania major | 96% | 100% |
V5BF65 | Trypanosoma cruzi | 78% | 100% |